Vimarsana
Biggest News Aggregation in the World

Allergy Immunology Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allergy Immunology Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allergy Immunology Program Today - Breaking & Trending Today

AAAAI Installs New President, Dr. Giselle Mosnaim, at 2021 Virtual Annual Meeting - Vimarsana News

AAAAI Installs New President, Dr. Giselle Mosnaim, at 2021 Virtual Annual Meeting

AAAAI Installs New President, Dr. Giselle Mosnaim, at 2021 Virtual Annual Meeting PRWeb FacebookTwitterEmail MILWAUKEE (PRWEB) March 02, 2021 The American Academy of Allergy, Asthma & Immunology (AAAAI) is pleased to introduce its 2021-2022 President, Giselle S. Mosnaim, MD, MS, FAAAAI. She was installed as AAAAI President yesterday evening during the Business Meeting that took place on the final day of the 2021 AAAAI Annual Meeting. “While I wish we could have met in person, the COVID-19 pandemic caused us to shift gears to a virtual meeting format, and it was a great success,” said Dr. ...

Ukko Secures $40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and Sensitivities - Vimarsana News

Ukko Secures $40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and Sensitivities

Ukko Secures $40 Million in Series B Funding Led by Leaps by Bayer to Overcome Food Allergies and Sensitivities Top industry leaders and venture firms unite behind Ukko's efforts to eliminate the world's most prevalent food allergies and sensitivities, including peanuts and gluten News provided by Share this article Share this article PALO ALTO, Calif., TEL AVIV, Israel and LEVERKUSEN, Germany, Jan. 27, 2021 /PRNewswire/ -- Ukko, a biotech company with the mission to eliminate food allergies and sensitivities, today announced $40 million in new Series B funding. Ukko harnesses artificial inte...